Applicant, as named in the Orange Book

Iterum Therap

Next listed expiry: Orlynvah on 23 Dec 2039. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Orlynvah probenecid; sulopenem etzadroxil	probenecid; sulopenem etzadroxil	213972	23 Dec 2039	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.